Literature DB >> 1908826

Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

F G Araujo1, B Morein.   

Abstract

An immunoglobulin G3 monoclonal antibody obtained by immunizing mice with a cell membrane preparation of epimastigotes of Trypanosoma cruzi was shown to agglutinate live epimastigotes, lyse blood-form trypanosomes, and partially protect mice by passive transfer. The main antigens recognized by the monoclonal antibody were located in the flagella of epimastigotes and blood-form trypanosomes. Antigens of epimastigotes, purified by affinity chromatography with the monoclonal antibody, were shown to be highly glycosylated and revealed a wide band with an Mr between 45,000 and 68,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. Immunization of mice with a small concentration of the affinity purified antigens incorporated into an antigen delivery system prepared with Quil A (Isotec AB, Lulea, Sweden), a saponin derivative, induced strong antibody and cell-mediated immune responses and protected 100% of the immunized animals against death due to challenge with 100 100% lethal doses of blood form trypanosomes. Protection was due to the use of the antigen delivery system, since mice immunized with equal concentrations of antigens alone or in combination with saponin had 100% mortality. The results suggest that small concentrations of epimastigote antigens obtained by biochemical methods and incorporated into the proper antigen delivery system may serve as a vaccine against Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908826      PMCID: PMC258112          DOI: 10.1128/iai.59.9.2909-2914.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier.

Authors:  K Lövgren; J Lindmark; R Pipkorn; B Morein
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

Review 2.  Autoimmunity in Chagas' disease.

Authors:  F Kierszenbaum
Journal:  J Parasitol       Date:  1986-04       Impact factor: 1.276

Review 3.  Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research.

Authors:  J J Marr; R Docampo
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

Review 4.  Vaccination against parasitic diseases: some alternative concepts for the definition of protective antigens.

Authors:  A Capron; J P Dessaint
Journal:  Ann Inst Pasteur Immunol       Date:  1988 Jan-Feb

5.  Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

6.  Immunizing effects in mice of two Toxoplasma gondii iscom preparations.

Authors:  A Uggla; F G Araujo; A Lunden; K Lövgren; J S Remington; B Morein
Journal:  Zentralbl Veterinarmed B       Date:  1988-05

7.  Use of antigen preparations of the amastigote stage of Trypanosoma cruzi in the serology of Chagas' disease.

Authors:  F G Araujo; D Guptill
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

8.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

Authors:  S G Reed
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

9.  Circulating Trypanosoma cruzi from the same cloned population show differences in the ability to infect cells and to cause lethal infection in mice.

Authors:  E H de Titto; D Israelski; F G Araujo
Journal:  Experientia       Date:  1987-12-01

10.  Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

View more
  3 in total

1.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

2.  A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.

Authors:  R Santori F; G S Paranhos-Bacalla; J Franco DA Silveira; L M Yamauchi; J E Araya; N Yoshida
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 3.  Experimental Vaccines against Chagas Disease: A Journey through History.

Authors:  Olivia Rodríguez-Morales; Víctor Monteón-Padilla; Silvia C Carrillo-Sánchez; Martha Rios-Castro; Mariana Martínez-Cruz; Alejandro Carabarin-Lima; Minerva Arce-Fonseca
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.